GAMMA Investing’s aTyr Pharma ATYR Stock Holding History

GAMMA Investing’s Portfolio ATYR Stock Details ATYR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-659	Closed	-$393	–	4412
2026 Q2	$393	Sell	659 -7,080	-91%	-$4.63K	﹤0.01%	4020
2026 Q1	$6.04K	Buy	+7,739	New	+$6.53K	﹤0.01%	3297

Other funds holding ATYR

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's ATYR Position: Q3 2026 in Review

GAMMA Investing sold out of aTyr Pharma (ATYR) in Q3 2026, closing a stake of 659 shares — an estimated $393 sold.

GAMMA Investing first reported a position in ATYR in Q1 2026 and held it in 2 quarters. The position peaked at $6.04K in Q1 2026. 4 funds tracked by Wall St. Rank hold ATYR as of Q3 2026.

GAMMA Investing reported no remaining aTyr Pharma position as of Q3 2026 after selling out during the quarter.
GAMMA Investing sold 659 aTyr Pharma shares in Q3 2026, an estimated $393.
GAMMA Investing first reported a position in aTyr Pharma in Q1 2026 and held it in 2 quarters.
GAMMA Investing's aTyr Pharma position peaked at $6.04K in Q1 2026.
4 funds tracked by Wall St. Rank held aTyr Pharma as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.